Neal L. Benowitz
University of California, San Francisco
826 Papers
9K Citations
Neal L. Benowitz is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Nicotine & Cotinine. The author has an hindex of 126, co-authored 792 publications. Previous affiliations of Neal L. Benowitz include Shaare Zedek Medical Center & University College London.
Chat about Author
Papers
Severe Carisoprodol Withdrawal After a 14-Year Addiction and Acute Overdose.
TL;DR: This case highlights an uncommon case of carisoprodol withdrawal that may be encountered by emergency physicians, and demonstrates that benzodiazepines may not be sufficient to suppress severe withdrawal symptoms.
7
Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency
TL;DR: The results suggest that NMR is related to tobacco use among persons enrolled in opioid treatment, as reported in general population smokers and may be a useful biomarker to include in future research assessing efficacy of tobacco cessation interventions in this population.
7
The chronic infusion of nicotine into the developing chick embryo does not alter tensity of (−)-[3H]nicotine-binding sites or vestibular function
TL;DR: Nicotine and cotinine were found in the serum and extraembryonic fluid, but nicotinic receptors were not up-regulated in the brains of animals infused with nicotine in comparison to controls, and Vestibular response thresholds also did not differ between nicotine-treated and control animals.
6
How the FDA Can Improve Public Health - Helping People Stop Smoking.
TL;DR: The FDA could take steps to encourage the development and marketing of consumer-desirable, effective smoking-cessation aids, which would represent an important contribution to public health as discussed by the authors . . .
6